You just read:

Genomic Health Presents New Data Demonstrating Value of Oncotype DX® to Optimize Breast Cancer Outcomes and Reduce Treatment Burden throughout Disease Continuum

News provided by

Genomic Health, Inc.

Dec 11, 2017, 07:00 EST